TINA-QUANT FERRITIN GEN.4 04885317190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2018-09-07 for TINA-QUANT FERRITIN GEN.4 04885317190 manufactured by Roche Diagnostics.

Event Text Entries

[119941935] This event occurred in (b)(6). (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[119941936] The customer questioned low results for multiple patients tested for ferr4 tina-quant ferritin gen. 4 (ferr4) on a cobas 6000 c (501) module. The date of event is not clear. The initial low ferr4 results were reported outside of the laboratory where the clinicians questioned them. The customer repeated 14 patient samples by the abbott architect method and all 14 patient samples were discrepant. Refer to attached data for the patient results. There was no allegation that an adverse event occurred. The c501 module serial number was (b)(4). The customer had no calibration or qc issues. It was discovered that the reagent cassette wasn't mixed and to exclude problems with the calibration curve, the customer downloaded the application again and put in a new reagent cassette that was mixed. Afterwards, calibration and qc were good however there were still issues with patient results. The customer performed additional patient comparisons and there were discrepant results between the c501 module and the abbott architect method again. Refer to attached data for these results. The customer stated that each day approximately 25% of the patients they test have extremely low results and when those patients are tested by another method the results are higher. The customer stated the other 75% of patients they test daily receive expected ferr4 results on the c501 module. The customer stated the patient samples affected are of good quality with no hemolysis or foam. The customer is using 13 mm sample tubes with rack adapters. The customer is not having problems with any other tests. The customer performed a precision test with good results. The customer also tested 5 patient samples on a cobas e 411 immunoassay analyzer, a cobas 8000 e 602 module and 2 abbott architect systems. The results between the 2 roche systems were similar and the results between the 2 abbott systems were similar, however, discrepant results were generated between the roche and abbott systems for 3 patient samples. Refer to attached data for these results. Investigations are ongoing.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1823260-2018-03026
MDR Report Key7855496
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2018-09-07
Date of Report2019-01-28
Date of Event2018-07-11
Date Mfgr Received2018-07-11
Date Added to Maude2018-09-07
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameTINA-QUANT FERRITIN GEN.4
Generic NameFERRITIN IMMUNOLOGICAL TEST SYSTEM
Product CodeDBF
Date Received2018-09-07
Model NumberNA
Catalog Number04885317190
Lot Number29079401
Device Expiration Date2019-10-31
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2018-09-07

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.